Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2024 Earnings Call Transcript
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2024 Earnings Call Transcript November 18, 2024 Cellectar Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.55 EPS, expectations were $-0.35. Operator: Ladies and gentlemen, thank you for …